Challenges in sentinel node pathology in the era of adjuvant treatment-Reference-Cited by-同舟云学术

Challenges in sentinel node pathology in the era of adjuvant treatment

Published:2020-06-29 Issue: Volume: Page:
ISSN:0022-4790
Container-title:Journal of Surgical Oncology
language:en
Short-container-title:J Surg Oncol

Author:

Franke Viola¹^ORCID,Madu Max F.¹^ORCID,Bierman Carolien²,Klop Willem M. C.³,Houdt Winan J.¹^ORCID,Wouters Michel W. J. M.¹^ORCID,Wiel Bart A.²^ORCID,Akkooi Alexander C. J.¹^ORCID

Affiliation:

1. Departments of Surgical OncologyNetherlands Cancer Institute ‐ Antoni van Leeuwenhoek Amsterdam The Netherlands

2. Division of PathologyNetherlands Cancer Institute ‐ Antoni van Leeuwenhoek Amsterdam The Netherlands

3. Department of Head and Neck SurgeryNetherlands Cancer Institute ‐ Antoni van Leeuwenhoek Amsterdam The Netherlands

Publisher

Wiley

Subject

Oncology,General Medicine,Surgery

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jso.26095

Reference29 articles.

1. Prolonged Survival in Stage III Melanoma with Ipilimumab Adjuvant Therapy

2. Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma

3. Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma

4. Adjuvant Dabrafenib plus Trametinib in Stage IIIBRAF-Mutated Melanoma

5. Sentinel-Node Biopsy or Nodal Observation in Melanoma

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The difficulty with measuring the largest melanoma tumour diameter in sentinel lymph nodes;Journal of Clinical Pathology;2024-02-20

2. The Association of Guideline-Concordant Sentinel Lymph Node Biopsy for Melanoma at Minority-Serving Hospitals;Annals of Surgical Oncology;2023-03-19

3. High discordance rate in assessing sentinel node positivity in cutaneous melanoma: Expert review may reduce unjustified adjuvant treatment;European Journal of Cancer;2021-05

4. Letter in reply: increase of sentinel lymph node melanoma staging in The Netherlands; still room and need for further improvement;Melanoma Management;2021-03